ADC’s – What Everyone with MBC Should Know about Antibody Drug Conjugates
Antibody drug conjugates (ADC’s), a novel class of anticancer agents, have been around for decades but recently great strides have been made in metastatic breast cancer. Next generation ADC’s, sometimes referred to as ‘ Trojan Horses’ have shown promising efficacy in all subtypes of MBC. Join Dr. Erika Hamilton, Director of Breast Cancer and Gynecologic […]
In a Nutshell: CA-125 and Ovarian Cancer
When it comes to CA-125 and ovarian cancer, there is often a lot of confusion. In this brief conversation with Dr. Richard Penson, Clinical Director of Medical Gynecologic Oncology at Massachusetts General Hospital, we’ll discuss the CA-125 blood test and how it’s used for ovarian cancer to give you a better understanding of the basics. […]
Not All Uterine Cancer is the Same: What to Know About Rare Uterine Cancers
While endometrial cancer is the most common type of uterine cancer, not all cancers are the same and there are less common endometrial subtypes (uterine serous carcinoma, carcinosarcoma) and other uterine cancers such as sarcomas that can occur. These rarer cancers can be more aggressive and harder to treat. Join Dr. Nita Lee, gynecologic oncologist […]
Let’s Talk About It: Breast Cancer – Ask Me Anything about Palliative Care/Support Care
Palliative care/Supportive care is available for anyone going through cancer treatment at any stage. We are bringing back one of the presenters from our April program, Debora Afezolli, MD, Assistant Professor, Geriatrics and Palliative Medicine at Mount Sinai, in an Ask Me Anything 30-40 minute format where all patients can have devoted time for questions […]
Optimizing the Management of Metastatic TNBC: Diagnostics, Treatments and Hope for the Future
The treatment for mTNBC is evolving with the identification of biomarkers and clinical trials revealing new treatment options. Join us to hear from our expert guests, Dr. Paolo Tarantino, an advanced research fellow at Dana-Farber Cancer Institute and at Harvard Medical School, and Dr. Ana Garrido-Castro, Breast Medical Oncologist at Dana-Farber Cancer Institute (DFCI) and […]
Report Back from SGO 2023: What’s New in Cervical Cancer?
Curious about what’s new in cervical cancer research? Join Dr. Evelyn Cantillo, gynecologic oncologist at Weill Cornell Medicine, as she shares the latest updates from the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer. Dr. Cantillo will also highlight what the research presented at the conference means for you and answer your […]
Scans and Ovarian Cancer: Everything You Want to Know
When you’re diagnosed with ovarian cancer, scans become an inevitable part of life. But what are the differences between the imaging tests? When should which scans be used? What about the pros and cons of each test? Join Dr. Kevin Holcomb, Vice-Chair of Gynecology and member of the Division of Gynecologic Oncology at Weill Cornell […]
When Cells Go Rogue and Become Breast Cancer
Let’s have a conversation about our bodies and learn about the why’s and how healthy cells mutate into cancer. Diva Whalen, Ph.D., Assistant Professor & Pre Health Advisor in Biology at Tougaloo College, discusses how our genetics, where we live, and stress can be major factors in how breast cancer forms, what happens once diagnosed, […]
Family Ties: Knowing Your Connection to Cancer (with MSK)
On April 20, join Memorial Sloan Kettering Cancer Center (MSK) and SHARE Cancer Support for a talk about family health history. At this talk, you will: Key Takeaways from Webinar Viewers: Learn what your family’s health history can tell you about your risk for cancer. Find out how to get genetic testing. Get helpful tips […]
